Biofil Chemicals and Pharmaceuticals

₹30.93As of Sun 8 Nov 2026, 12:00 UTC

NSE:BIOFILCHEMHealthcare

Country India

PE (Fwd) 16.41

TSR 9Y CAGR 3.37%

Div yield —

ROE —

Drug Manufacturers (Specialty & Generic)

Beta (5Y) 0.58

PE TTM 18.07

TSR TTM (22.17%)

Mkt cap ₹494.1M

ROIC —

SE Grade™

Value

Quality

Moat

—

1Y Price

Reference

₹35

11.81%

134.59%

Price below Reference Value

TTM

FYE 31 Mar INR

FY2017

FY2018

FY2019

FY2020

FY2021

FY2022

FY2023

FY2024

FY2025

FY2026

FY2027E

Trend

10Y

Peers

284.0

Revenue₹M

—

223.8

300.4

404.1

335.8

284.0

298.8

6.13%

(15.45)

Revenue growth%

—

34.19

34.54

(16.89)

(15.45)

5.24

9.37

—

8.03

Gross margin%

—

12.80

8.53

6.80

7.64

8.03

7.90

8.03

1.74

Operating margin%

—

4.62

2.78

2.23

2.17

1.74

1.69

2.23

9.81

Net margin%

—

3.12

1.87

1.76

1.66

9.81

9.77

1.87

18.07

P/E ratio (avg)x

—

165.4

155.6

133.0

210.7

22.22

17.24

155.6

—

101.7

EV/EBITx

—

111.7

104.5

104.8

161.3

125.0

99.90

111.7

—

FCF yield (avg)%

—

FCF margin%

—

FCF / Net incomex

—

ROIC%

—

100

—

Return on equity%

—

Return on assets%

—

1.71

EPS₹

—

0.43

0.34

0.44

0.34

1.71

1.79

41.33%

—

399.55

EPS growth%

—

(19.76)

26.55

(21.36)

399.55

4.82

3.40

—

Bookvalue per sh₹

—

FCF per share₹

—

Dividend per sh₹

—

Div yield (avg)%

—

Payout ratio%

—

16.27

Shares (diluted)M

—

16.27

◌16.27

—

100

—

Buyback yield%

—

◌—

—

100

—

D/E ratiox

—

0.503

Enterprise value₹B

—

1.155

0.872

0.943

1.175

0.619

0.503

(14.45%)

—

LT debt₹M

—

Peers (US$5.326M)

Cap (US$)

Vaishali Pharma Limited

9.419M

20.01x

Mangalam Drugs…

4.954M

—

Vivimed Labs Limited

4.777M

—

Sonoma Pharmaceuticals…

5.315M

—

Capital

TTM

10Y

Leveragex

—

EBIT/Intx

54.41

22.79

Own earn%

—

Sh yield%

—

Owners

Insiders/Inst%

17.45

—

Short interest%

—

SBC / revenue%

—

Record

10Y

Profitable years

5/5

Revenue growth years

2/4

EPS growth years

2/4

Dividend streakyrs

Op margin range%

2–5

$1 testx

—

Incr. ROIC%

—

Biofil Chemicals and Pharmaceuticals Limited engages in the manufacturing and trading of pharmaceutical products in India. It operates through Pharma and Chemical segments.

Growth vs revenue

Latest

Trend

4Y CAGR

Rel growth

Revenue

₹284.0M

6.13%

1.00×

Cost of revenue

₹261.1M

7.55%

1.05×

Operating expenses

₹17.86M

(0.63%)

0.77×

Revenue by region

No breakdown available

Reinvestment returns

n/m

Trend

Reinvestment rate

n/m

Return on capital

n/m

Spread over hurdle

n/m